All News

Physical activity can help overcome comorbidities associated with aromatase inhibitor treatment for breast cancer.

Post-breast cancer treatment with aromatase inhibitors may cause adverse events.

Antibody-based therapy may be a novel addition to immunotherapies for breast cancer, lung cancer, and colon cancer.

A modifiable artificial heart allows researchers to study how gene mutations affect cardiac health.

Cognitive impairment more prevalent in patients with HIV coinfection than in those with hepatitis C infection alone.

Rituximab found to be safe and effective in patients with primary progressive MS.

As the voice of independent pharmacists, the National Community Pharmacists Association (NCPA) works to align our advocacy efforts with the most pressing legislative priorities of our members.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Pronunciation errors threaten patient safety, but what can we do about them?

With snow falling across the United States, the only thing on my mind is a sunny escape.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

Cancer cells are much less efficient in removing hydrogen peroxide than normal cells.

A New Hampshire-based physician assistant (PA) is at the center of an investigation for his role in a fentanyl spray scam, according to NH1.

A $450,000 research grant is targeting triple negative breast cancer and HER2-positive breast cancer.

Targeted therapy for sleep disorders more effective in patients with muscular dystrophy.

Researchers in England set out to determine whether the risk of diabetes development was present at the onset of schizophrenia, as opposed to after a period of time with the illness.

The FDA has announced 2 new draft guidances for medical product communications, such as off-label information and communicating cost-effective data

The majority of HIV-positive individuals 50 years or older live on or below the poverty line.

Findings suggest that a majority of profits from prescription drug sales are going to supply chain entities and discounts.

Since the beginning of January, more than 63,000 individuals chose marketplace health plans.

Humira is currently approved to treat rheumatoid arthritis, inflammatory bowel disease, and psoriasis.

Kalytera will acquire Talent Biotechs phase 2 trial of cannabidiol in graft versus host disease.

Changing warfarin management may prevent patients from receiving too much or too little of the drug.

Level of emotional distress after prostate cancer diagnosis increases likelihood of choosing surgery over active surveillance.

Top news of the day from across the health care landscape.

Children born to mothers who took heartburn medication were more likely to visit the physician for asthma symptoms.

Providers need to monitor lack of physical activity and poor diet among patients with multiple sclerosis.

Majority of patients do not adhere to dietary guidelines set by the US Department of Agriculture.